The company expired its plan on February 23, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.645 USD | -5.15% | +16.36% | +14.63% |
04:26pm | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
02:57pm | Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.63% | 3.02B | |
+34.54% | 472B | |
+6.75% | 138B | |
+32.61% | 98.36B | |
+7.39% | 93.44B | |
+59.77% | 59.13B | |
+18.28% | 47.5B | |
+30.27% | 39.41B | |
+0.02% | 35.99B | |
+15.40% | 29.22B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- GoodRx Holdings, Inc.'s Equity Buyback announced on February 28, 2022, has expired.